Moxifloxacin Ratiopharm (Moxifloxacin)

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections affecting the respiratory tract and skin.

• Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical outcomes.
• Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
• Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications.
• Skin and skin‑structure infections: eliminates pathogenic bacteria and promotes wound healing.

• Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these targets, it prevents bacterial DNA supercoiling and separation, leading to inhibition of bacterial cell division and ultimately bacterial cell death. This bactericidal activity is effective against a wide range of Gram‑positive and Gram‑negative organisms.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: loose stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects

• Tendon rupture: sudden tendon pain or swelling, especially in the Achilles.
• QT interval prolongation: risk of cardiac arrhythmia.
• Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

Before prescribing Moxifloxacin, clinicians should consider several safety aspects.

• Renal function assessment: adjust use in patients with impaired kidney function.
• Tendon health monitoring: advise patients to report tendon pain or inflammation.
• QT‑prolonging drug avoidance: avoid concurrent use with other QT‑prolonging agents.
• Seizure history evaluation: use cautiously in patients with a history of seizures.
• Hepatic impairment consideration: monitor liver function tests during therapy.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• QT‑prolonging agents: co‑administration may increase risk of cardiac arrhythmias.
• Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin.
• Warfarin: may enhance anticoagulant effect and raise INR.

Moderate Interactions (Monitor Closely)

• Corticosteroids: combined use may raise the risk of tendon rupture.
• Theophylline: moxifloxacin can increase theophylline plasma concentrations, requiring monitoring.